What is the IV dose of digoxin (digitalis glycoside) used for acute decompensated heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Dosing of Digoxin for Acute Decompensated Heart Failure

For acute decompensated heart failure, the recommended IV loading dose of digoxin is 0.25-0.5 mg IV bolus, which can be repeated up to a maximum loading dose of 1.0 mg over 24 hours, administered at 6-8 hour intervals. 1

Dosing Algorithm

Initial Loading Dose

  • Standard adult loading dose: 0.25-0.5 mg IV bolus over 2 minutes 1
  • Administer over at least 5 minutes to prevent systemic and coronary vasoconstriction 2
  • Can repeat 0.25 mg IV bolus up to maximum loading dose of 1.0 mg over 24 hours 1

Dose Adjustments Based on Patient Factors

  • Age >70 years: Use lower dose (0.125 mg) 1, 3
  • Impaired renal function: Use lower dose (0.125 mg) 1, 3
  • Low lean body mass: Use lower dose (0.125 mg) 1, 3
  • Concomitant medications that affect digoxin levels (amiodarone, verapamil, diltiazem): Reduce dose by 30-50% 1, 3

Administration Guidelines

  • Avoid bolus administration to prevent systemic and coronary vasoconstriction 2
  • Can be administered undiluted or diluted with a 4-fold or greater volume of sterile water, normal saline, or 5% dextrose 2
  • Do not mix with other drugs in the same container or IV line 2

Clinical Considerations

Indications

  • Acute decompensated heart failure, particularly with atrial fibrillation and rapid ventricular rate 1, 3
  • Useful for initial control of ventricular rate in patients with rapid atrial fibrillation and heart failure 1, 3

Contraindications

  • Second or third-degree heart block without a pacemaker 1, 3
  • Pre-excitation syndromes 1, 3
  • Previous evidence of digoxin intolerance 1, 3

Monitoring

  • Monitor serum electrolytes (potassium, magnesium, calcium) 3
  • Target serum digoxin concentration: 0.5-1.0 ng/mL 1, 3
  • Higher levels (>2 ng/mL) are associated with toxicity 1

Potential Adverse Effects

  • Cardiac arrhythmias: Ectopic and re-entrant rhythms, heart block 1
  • Gastrointestinal symptoms: Anorexia, nausea, vomiting 1
  • Neurological complaints: Visual disturbances, disorientation, confusion 1

Important Caveats

  • Loading doses are not necessary for chronic heart failure management but may be needed in acute settings 1, 4
  • Digoxin is not indicated as primary treatment for stabilization of acutely decompensated heart failure but can be initiated after emergency treatment 4
  • Risk of toxicity increases with hypokalemia, hypomagnesemia, or hypothyroidism 1
  • Recent evidence suggests that digoxin initiation after acute heart failure may help reduce 30-day readmission rates in patients with reduced ejection fraction 5

Maintenance Therapy Transition

  • After initial IV loading, transition to oral maintenance therapy with 0.125-0.25 mg daily based on renal function, age, and other clinical factors 1, 3
  • Maintenance dose should be adjusted to achieve serum levels of 0.5-1.0 ng/mL 1, 3

By following this evidence-based dosing algorithm for IV digoxin in acute decompensated heart failure, clinicians can optimize treatment while minimizing the risk of adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Digoxin remains useful in the management of chronic heart failure.

The Medical clinics of North America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.